Amgen

aid: amgen
url: https://raw.githubusercontent.com/api-evangelist/amgen/refs/heads/main/apis.yml
name: Amgen
description: >-
  Amgen is committed to unlocking the potential of biology for patients suffering from serious
  illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
  As a pioneer in biotechnology since 1980, Amgen uses living cells to make biologic medicines
  addressing cardiovascular metabolic conditions, oncology, inflammation, rare diseases, and bone health,
  operating in approximately 100 countries worldwide.
image: https://kinlane-productions2.s3.amazonaws.com/apis-json/apis-json-logo.jpg
tags:
  - Biotechnology
  - Biopharmaceutical
  - Oncology
  - Inflammation
  - Cardiovascular
  - Rare Disease
  - Biosimilars
  - Life Sciences
created: '2024-01-01'
modified: '2026-04-19'
specificationVersion: '0.18'
apis:
  - aid: amgen:website
    name: Amgen Website
    tags:
      - Biotechnology
      - Biopharmaceutical
      - Life Sciences
    image: https://kinlane-productions2.s3.amazonaws.com/apis-json/apis-json-logo.jpg
    baseURL: https://www.amgen.com
    humanURL: https://www.amgen.com
    properties:
      - type: Website
        url: https://www.amgen.com
    description: >-
      Amgen discovers, develops, manufactures, and delivers innovative biologic medicines
      for patients with serious illnesses. The company does not currently publish a public
      developer API.
common:
  - type: Portal
    url: https://www.amgen.com
  - type: Blog
    url: https://www.amgen.com/stories
  - type: PrivacyPolicy
    url: https://www.amgen.com/privacy-statement
  - type: TermsOfService
    url: https://www.amgen.com/terms-of-use
  - type: Support
    url: https://www.amgen.com/contact-amgen
  - type: LinkedIn
    url: https://www.linkedin.com/company/amgen
  - type: X
    url: https://twitter.com/AmgenNews
  - type: YouTube
    url: https://www.youtube.com/amgen
  - type: Features
    data:
      - name: Biologic Drug Discovery
        description: Pioneering use of living cells and human genetic data combined with AI and generative biology to discover novel biologic medicines.
      - name: Oncology Therapeutics
        description: Cancer medicines targeting solid tumors and hematologic malignancies including innovative BiTE and antibody therapies.
      - name: Cardiovascular and Metabolic Medicines
        description: Medicines addressing heart disease, high cholesterol (Lp(a)), obesity, and obesity-related metabolic conditions.
      - name: Inflammation Therapeutics
        description: Treatments for inflammatory conditions including chronic rhinosinusitis with nasal polyps, asthma, and other immune-mediated diseases.
      - name: Rare Disease Medicines
        description: Therapies for rare conditions including IgG4-related disease (IgG4-RD), generalized myasthenia gravis, and other orphan indications.
      - name: Bone Health Products
        description: Medicines for osteoporosis, bone metastases, and other bone health conditions including PROLIA and XGEVA.
      - name: Biosimilars
        description: High-quality biosimilar medicines providing more affordable alternatives to reference biologic therapies across multiple therapeutic areas.
      - name: AI-Driven Drug Development
        description: Application of artificial intelligence, generative biology, and advanced data science to accelerate drug discovery and clinical trial optimization.
  - type: UseCases
    data:
      - name: Cancer Treatment
        description: Providing oncology medicines for patients with solid tumors and blood cancers through innovative biologic and targeted therapies.
      - name: Heart Disease Prevention
        description: Reducing cardiovascular risk with medicines targeting LDL cholesterol, Lp(a), and other cardiovascular risk factors.
      - name: Inflammatory Disease Management
        description: Managing chronic inflammatory conditions with targeted biologic therapies for patients with severe unmet medical needs.
      - name: Rare Disease Treatment
        description: Delivering life-changing therapies to patients with rare and ultra-rare diseases where few or no other treatments exist.
      - name: Biosimilar Access
        description: Improving patient access to biologic therapies through high-quality, lower-cost biosimilar medicines.
      - name: Weight Management
        description: Addressing obesity and obesity-related conditions with novel medicines targeting metabolic pathways.
  - type: Integrations
    data:
      - name: Amgen SupportPlus
        description: Patient support program providing financial assistance, insurance navigation, and access services for Amgen medicines.
      - name: Clinical Trials Network
        description: Global clinical research network conducting Phase I through Phase III trials across therapeutic areas with AI-optimized trial design.
      - name: Amgen Biosimilars
        description: Portfolio of biosimilar medicines offered through partnerships with healthcare systems globally to improve treatment access.
  - type: Integrations
    url: https://www.amgen.com/partners
integrations:
  - name: Academic Collaborations
  - name: Suppliers
  - name: Wholesalers
maintainers:
  - FN: API Evangelist
    email: [email protected]